Clincosm LogoSign in Get a demo

Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

Sponsor
University of Zurich (Other)
Overall Status
Completed
CT.gov ID
NCT01429883
Collaborator
(none)
36
Enrollment
1
Location
42.1
Duration (Months)
0.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the investigators want to ask for pain, pain reduction and function.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients with either Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get a shock wave therapy in our clinic of rheumatology as planned. During our study the investigators ask for pain, pain reduction and function (all questionnaires).

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    36 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?
    Study Start Date :
    Jul 1, 2011
    Actual Primary Completion Date :
    Jan 1, 2015
    Actual Study Completion Date :
    Jan 1, 2015

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion criteria:

      -Patients with:

      • Fascititis plantaris,

      • Achillodynie,

      • Periarthropathia humerosacpularis calcarea or

      • Epicondylopathia humeri /radii, who got the shock wave therapy.

      Exclusion criteria:

      • Anticoagulation,

      • Sepsis

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 University Hospital Zurich Switzerland

      Sponsors and Collaborators

      • University of Zurich

      Investigators

      • Study Director: 01 Studienregister MasterAdmins, UniversitaetsSpital Zuerich
      • Principal Investigator: Sandra Blumhardt, MD, University Hospital Zurich, Division of Rheumatology

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      University of Zurich
      ClinicalTrials.gov Identifier:
      NCT01429883
      Other Study ID Numbers:
      • ESWTRUZ01
      First Posted:
      Sep 7, 2011
      Last Update Posted:
      Jun 3, 2015
      Last Verified:
      May 1, 2015
      Additional relevant MeSH terms:
      Fasciitis
      Fasciitis, Plantar
      Periarthritis

      Study Results

      No Results Posted as of Jun 3, 2015